Silicon Valley bank sees sharp increase in healthcare startup investments coming for next two years
While $7.5 billion went into healthcare startups venture capital investments as of 2010, by 2015 that total spiked to nearly $10.5 billion, according to the Silicon Valley Bank Healthcare Investments and Exits Mid-Year Report.
What’s more, the study's authors see that strong investment continuing over at least the next two years.
Funding for early-stage startups is up in all sectors so far this year. Biopharma alone is on pace for over 100 Series A deals, with $2 billion in invested capital — up 30 percent over 2015.
If investment velocity continues, that would be a record high.
Much of this activity has focused on pre-clinical technologies for oncology, neurology and orphan/rare disease companies.
Oncology, in fact, is leading the charge in new biopharma investments. From 2015 through the first half of this year, there have been 62 deals representing around $2.4 billion.
Device deals have also already eclipsed 2015 totals, with significant investment activity in neurology, cardiovascular and surgical companies.
Twitter: @JELagasse
